RCT with 103 patients in Pakistan comparing ivermectin and CQ, showing significantly lower PCR+ at day 7 with ivermectin. Results from .
Asghar et al., 1/16/2021, Randomized Controlled Trial, Pakistan, South Asia, preprint, 1 author, dosage 200μg/kg days 1, 8.
risk of no virological cure, 82.1% lower, RR 0.18, p < 0.001, treatment 50, control 50, day 7.
Effect extraction follows pre-specified rules prioritizing more serious
outcomes. For an individual study the most serious outcome may have a smaller
number of events and lower statistical signficance, however this provides the
strongest evidence for the most serious outcomes when combining the results of